Read the latest positive news, breakthroughs, and inspiring stories about insulin prices, curated daily by BrightWire.
Americans with diabetes just got major financial relief. A federal settlement with CVS Caremark will slash inflated insulin prices and could save patients up to $8.5 billion over the next ten years.
CVS Caremark has agreed to settle federal charges that it inflated insulin prices, promising changes that could make the lifesaving diabetes medication more affordable. The move follows similar action by another major pharmacy manager, signaling real progress on drug pricing.
A landmark settlement with pharmacy giant Express Scripts will force major changes that could save Americans up to $7 billion on insulin costs over the next decade. The Federal Trade Commission says the company artificially inflated prices and blocked access to the lifesaving diabetes medication.